What distinguishes the new device system is that it is has a main column intended to protect the aorta and exclude the aneurysm from blood flow and two offshoot devices intended to protect the two renal arteries. The device is not commercially available in the United States, and will only be available at selected clinical study sites for investigational use.
Courtesy of Endologix Inc
The Ventana stent graft system
"These devices could allow management of aortic aneurysms that extend up to and may involve the renal arteries," said Methodist DeBakey Heart & Vascular Center Medical Director Alan Lumsden, M.D., who is leading the trial at Methodist. "They permit branches to be inserted through the main device and into the renal arteries in order to maintain blood flow to the kidneys. This has not been part of currently available devices. The device is meant to address the needs of patients whose aortic aneurysms are more extensive."
Stent grafts are light, metal-frame cylinders surrounded by a cloth-like covering. Similar devices are used to strengthen and protect blood vessels that have developed aneurysms -- weakened to the point that rupture, or dissection, is possible. An aneurysm is a weakening or ballooning in a blood vessel wall.
The aorta extends up and out of the heart and down to the lower back. Abdominal aortic aneurysm (AAA) is a weakening of the lower half of the aorta. That weakening may cause the aorta to bow outward, as if swollen, or even to develop a bubble. If the aneurysm dissects, blood spills into the body. The lost blood supply to the brain and other important organs is usually deadly.
The Ventana stent graft system received an investigational device exemption (IDE) conditional approval from the United States Food and Drug Administration recently for the purpose of evaluating its safety and feasibility in treating certain types of abdominal aortic aneurysms that are near to or may involve the renal arteries. In November, Methodist will be the procedural training site for medical researchers participating in the national feasibility study. A pivotal trial will also be conducted at these and additional research sites.
Many patients have aneurysms that extend from the aorta into one or both of the arteries that lead to the kidneys, organs that help the body remove toxins and that help regulate blood pressure. Keeping those aneurysms from rupturing is of great concern, Lumsden says.
"The open repair of aneurysms involving the renal arteries is called a juxtarenal, pararenal, or thoracoabdominal aneurysm repair," Lumsden said. "This has involved opening both the chest and abdomen at the same time and represents one of the largest procedures we ever perform. Many patients are just not able to tolerate the operation. In those who undergo surgery the complication rate is high and the recovery very difficult. We're hopeful this new device will permit an endovascular treatment to be extended to a much bigger group of patients."
Lumsden is also chair of Methodist's Department of Cardiovascular Surgery, a professor of cardiothoracic surgery in the Cornell University Weill Cornell Medical College, and a fellow of the American College of Surgeons.
Endologix Inc. develops and manufactures minimally invasive treatments for aortic disorders. Additional information about the company can be found at http://www.endologix.com.
Journalists interested in speaking with Dr. Lumsden should contact David Bricker, The Methodist Hospital, at 832-667-5811 or email@example.com
David Bricker | Newswise Science News
Novel breast tomosynthesis technique reduces screening recall rate
21.02.2017 | Radiological Society of North America
Biocompatible 3-D tracking system has potential to improve robot-assisted surgery
17.02.2017 | Children's National Health System
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
24.02.2017 | Life Sciences
24.02.2017 | Life Sciences
24.02.2017 | Trade Fair News